U.S. health officials documented 112 measles cases in pregnant women and 13 congenital cases in newborns from January 1, 2025, through September 28, 2026.
The findings, detailed in a preliminary analysis published by NEJM Evidence in a collaboration with CIDRAP, describe pregnancy-related measles cases and congenital measles. Nearly one-quarter of the infected pregnant women were hospitalized for complications unrelated to labor, such as pneumonia and respiratory failure. One patient required intensive care, some delivered preterm, and two lost their pregnancies.
The vast majority of the infected expectant mothers were unvaccinated or had unknown vaccination statuses. The data collected by researchers primarily from the U.S. Centers for Disease Control and Prevention across 16 jurisdictions show that 108 of the 112 cases were tied to outbreaks involving 50 or more cases.
In total, 110 of the infected women had not received any doses of the measles, mumps, and rubella vaccine or possessed an unknown vaccination record, while 26 pregnant women were admitted to a hospital for causes not related to labor and childbirth.
Scientists at the Centers for Disease Control and Prevention reported that the new study serves as a preliminary analysis published in the New England Journal of Medicine Evidence, documenting how infections during pregnancy have picked up as the highly contagious virus resurges across the country.
Among 19 live births recorded in the data, eight babies were born preterm and eight required admission to a neonatal intensive care unit. Thirteen infants tested positive for the measles virus via polymerase chain reaction testing, confirming congenital transmission.

Six of those infants developed symptoms. One baby presented “with symptoms compatible with meningoencephalitis,” a life-threatening inflammation of the brain and surrounding membranes, according to the public health report.
Officials recommend immunoglobulin at birth for neonates exposed in utero to reduce morbidity risks. The CDC specifically advises that pregnant women without prior documented MMR vaccination or other evidence of immunity who face exposure to measles should receive postexposure prophylaxis utilizing intravenous immunoglobulin.
“This is a brand new phenomenon,” said Michael Osterholm of the University of Minnesota’s Center for Infectious Disease Research and Policy.
Osterholm added, “This is much worse than we thought.”
“We’re now seeing levels of measles that we haven’t seen in 30 years,” said Dr. Adam Ratner, a member of the American Academy of Pediatrics’ infectious diseases committee. “When you have measles under control, congenital measles doesn’t happen.”
These lower rates have fueled the spread of the virus to such an extent that the Pan American Health Organization was expected to officially announce that the U.S. has lost the measles-free status it’s had. Over the past two years, the CDC reported more than 7,500 measles cases nationwide. Because the measles, mumps, and rubella shot is a live-attenuated vaccine, it is not recommended during pregnancy.
Readers wishing to evaluate personal health risks or explore vaccination guidance should consult qualified medical professionals for appropriate healthcare advice.
Earlier coverage: NEJM Evidence Study Shows Measles Risks for Pregnant Women in U.S.